AffiliationTullamore General Hospital, Ireland.
Antineoplastic Agents/therapeutic use
Boronic Acids/therapeutic use
Immunologic Factors/therapeutic use
Patient Education as Topic
Protease Inhibitors/therapeutic use
Stem Cell Transplantation
Thalidomide/analogs & derivatives/therapeutic use
MetadataShow full item record
CitationBr J Nurs. 2010 Dec 9-2011 Jan 13;19(22):1415-21.
JournalBritish journal of nursing (Mark Allen Publishing)
AbstractMyeloma is a challenging blood cancer characterized by bone destruction, hypercalcaemia, renal insufficiency and anaemia. Although myeloma remains incurable, recent advancements in treatments have resulted in significant improvements in morbidity. The use of immunomodulatory drugs-thalidomide, lenalidomide, pomalidomide (in clinical trials)-and the proteasome inhibitor, bortezomib, in conjunction with conventional chemotherapy and supportive therapies, have resulted in a significant shift in approaches to treatment and an improvement in patients' quality of life. Nurses must remain up-to-date with current treatments for myeloma and their related side-effects. In addition, nurses play a key role in the coordination of a multidisciplinary approach to care for myeloma patients.
- Multiple myeloma.
- Authors: Laubach J, Richardson P, Anderson K
- Issue date: 2011
- The emerging role of novel therapies for the treatment of relapsed myeloma.
- Authors: Richardson PG, Hideshima T, Mitsiades C, Anderson KC
- Issue date: 2007 Feb
- Diagnosis and the current trends in multiple myeloma therapy.
- Authors: Dmoszyńska A
- Issue date: 2008 Oct
- Diagnosis and therapy of multiple myeloma.
- Authors: Palumbo A, Cerrato C
- Issue date: 2013 May
- Advancing access to myeloma treatment: administration, side effects, and implications for survival.
- Authors: Davies MJ
- Issue date: 2006